Each unit equals 0.2 mg Higher concentrations mean you inject less volume for the same dose
They may or may not include updated dosing instructions
That discontinuation rate is remarkably low for this class of drugs
This reluctance is likely to be at least partially attributable to the fact that, until recently, all GLP-1RAs were available as subcutaneous (s.c.) injections, given twice daily (exenatide [13]), once daily (lixisenatide [14] and liraglutide [15]), or once weekly (semaglutide [16], dulaglutide [17], and exenatide extended release [18]), a route that may be less preferable to some patients compared with oral administration [1, 19]
P., Valyasevi, R
I started experiencing appetite suppression after about 4 weeks, but you should notice a significant difference at around the 12 to 16 week-mark